Italian Life Sciences Database

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

By: GlobenewsWire - 03 Dec 2019

Novo Nordisk A/S - Share repurchase programme

By: GlobenewsWire - 02 Dec 2019

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

HONG KONG, Nov. 26, 2019 /PRNewswire/ -- Novoheart ("Novoheart" or the "Company") (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, is pleased to announce a collaboration with global biopharmaceutical company AstraZeneca, in an effort to develop the world's first human-specific... Read more ››

By: PR Newswire Association LLC. - 26 Nov 2019

Novo Nordisk A/S – Share repurchase programme

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Sanofi: information concerning the total number of voting rights and shares, October 2019

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

By: Nasdaq / GlobenewsWire - 20 Nov 2019

« 1 2 3 4 5 6 7 »

Looking for companies outside of Italy?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2020
- Basel: R&D Data Intel Leaders Forum
- Nice: AgeingFIT
February 2020
- Zürich: Swiss Nordic Bio 2020

See Events »

Add an Event »

Latest company news

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.
23 Jan 2020 (GlobenewsWire)

SI-BONE Announces Pricing of Public Offering of Common Stock
23 Jan 2020 (GlobenewsWire)

SI-BONE Announces Launch of Public Offering of Common Stock
21 Jan 2020 (GlobenewsWire)

News in the Life Sciences Industry

ALK – Financial calendar for the 2020 financial year

Novo Nordisk A/S – Share repurchase programme

SI-BONE, Inc. Announces CIGNA Establishes Positive Coverage for MIS SI Joint Fusion using the iFuse Implant System

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

Sanofi CEO unveils new strategy to drive innovation and growth

Novo Nordisk A/S – Share repurchase programme

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

SI-BONE Names Jeryl (“Jeri”) Hilleman to Board of Directors

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SI-BONE to Participate at the 31st Annual Piper Jaffray Healthcare Conference on December 5, 2019

Novo Nordisk A/S - Share repurchase programme

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, October 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Novo Nordisk A/S – Share repurchase programme

Trading in Novo Nordisk shares by board members, executives and associated persons on 14 November 2019

Looking for companies outside of Italy?

Partners

Upcoming Life Sciences Events

Latest company news